Found 15 results
Author Title [ Type(Desc)] Year
Filters: Author is Wolff, MC  [Clear All Filters]
Journal Article
B. S. Graham, McElrath, M. J., Connor, R. I., Schwartz, D. H., Gorse, G. J., Keefer, M. C., Mulligan, M. J., Matthews, T. J., Wolinsky, S. M., Montefiori, D. C., Vermund, S. H., Lambert, J. S., Corey, L., Belshe, R. B., Dolin, R., Wright, P. F., Korber, B. T., Wolff, M. C., and Fast, P., Analysis of Intercurrent Human Immunodeficiency Virus Type 1 Infections in Phase I and II Trials of Candidate AIDS Vaccines, J Infec Dis, vol. 177, pp. 310-319, 1998.
L. H. Moulton, Wolff, M. C., Brenneman, G., and Santosham, M., Case-Cohort Analysis of Case-Coverage Studies of Vaccine Effectiveness, Am J Epidemiol, vol. 142, no. 9, pp. 1000-1006, 1995.
J. C. King, Treanor, J., Fast, P. E., Wolff, M. C., Yan, L., Iacuzio, D., Readmond, B., O’Brien, D., Mallon, K., Highsmith, W. E., Lambert, J. S., and Belshe, R. B., Comparison of the safety, vaccine virus shedding and immunogenicity of influenza virus vaccine, trivalent, types A and B, live-cold-adapted (LAIV) administered to HIV-infected and non-HIV-infected adults, J Infec Dis, vol. 181, pp. 725-8, 2000.
B. R. Luce, Zangwill, K. M., Palmer, C. S., Mendelman, P., Yan, L., Wolff, M. C., Cho, I., Marcy, M., Iacuzio, D., and Belshe, R. B., Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy children, Pediatrics, vol. 108, p. E24, 2001.
M. Rennels, Englund, J. A., Bernstein, D. I., Losonsky, G. A., Anderson, E. L., Pichichero, M. E., Munoz, F. M., and Wolff, M. C., Diminution of the Anti-PRP response to a combined DtaP/Hib vaccine by concurrent inactivated poliovirus vaccination, Ped J Infec Dis, vol. 19, pp. 417-23, 2000.
J. J. Treanor, Schiff, G. M., Couch, R. B., Cate, T. R., Brady, R. C., Hay, C. M., Wolff, M. C., She, D., and Cox, M. J. C., Dose-Related Safety and Immunogenicity of A Trivalent Baculovirus-Expressed Influenza-Virus Hemagglutinin Vaccine in Elderly Adults, J Infec Dis, vol. 193, pp. 1223-1228, 2006.
R. B. Belshe, Mendelman, P. M., Treanor, J., King, J., Gruber, W., Piedra, P., Bernstein, D. I., Hayden, F. G., Kotloff, K., Zangwill, K., Iacuzio, I., and Wolff, M. C., The efficacy of live attenuated, cold adapted, trivalent, intranasal, influenza virus vaccine in children, N Engl J Med, vol. 338, pp. 1405-12, 1998.
R. B. Belshe, Gruber, W., Mendelman, P. M., Cho, I., Reisinger, K., Block, S., Wittes, J., Iacuzio, D., Piedra, P., Treanor, J., King, J., Kotloff, K., Bernstein, D. I., Hayden, F. G., Zangwill, K., Yan, L., and Wolff, M. C., Efficacy of Vaccination with Live Attenuated, Cold-Adapted, Trivalent, Intranasal Influenza Virus Vaccine Against a Variant (A/Sidney) not Contained in the Vaccine, J Pediatric, vol. 136, pp. 168-175, 2000.
I. M. Longini, Halloran, M. E., Nizam, A., Wolff, M. C., Mendelman, P. M., Fast, P. E., and Belshe, R. B., Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic control, Vaccine, vol. 18, pp. 1902-9, 2000.
L. A. Jackson, Chen, W. H., Stapleton, J. T., Dekker, C. L., Wald, A., Brady, R. C., Edupuganti, S., Winokur, P., Mulligan, M. J., Keyserling, H. L., Kotloff, K. L., Rouphael, N., Noah, D. L., Hill, H., and Wolff, M. C., Immunogenicity and Safety of Varying Dosages of a Monovalent 2009 H1N1 Influenza Vaccine Given With and Without AS03 Adjuvant System in Healthy Adults and Older Persons, J Infect Dis, vol. 206, pp. 811-820, 2012.
K. J. Meador, Baker, G. A., Finnell, R. H., Kalayjian, L. A., Liporace, J. D., Loring, D. W., Mawer, G., Pennell, P. B., Smith, J. C., and Wolff, M. C., In Utero Antiepileptic Drug Exposures: Differential IQ Outcomes in Children of Women With Epilepsy, Neurology, vol. 67, pp. 407-412, 2006.
T. G. Boyce, Gruber, W. C., Coleman-Dockery, S. D., Sannella, E. C., Reed, W. G., Wolff, M. C., and Wright, P. F., Mucosal immune response to trivalent live-attenuated transnasal influenza vaccine in children, Vaccine, vol. 18, pp. 82-8, 1999.
D. L. Noah, Hill, H., Hines, D., White, E. L., and Wolff, M. C., Qualification of the Hemagglutination Inhibition Assay in Support of Pandemic Influenza Vaccine Licensure, Clin Vaccine Immunol, vol. 16, pp. 558-566, 2009.
J. J. Treanor, Campbell, J., Zangwill, K. M., Rowe, T., and Wolff, M. C., Safety and Immunogenicity of an Inactivated Subvirion Influenza A (H5N1) Vaccine, N Engl J Med, vol. 354, pp. 1343-1351, 2006.
N. B. Halasa, Gerber, M. A., Berry, A. A., Anderson, E. L., Winokur, P., Keyserling, H., Eckard, A. R., Hill, H., Wolff, M. C., McNeal, M. M., Edwards, K. M., and Bernstein, D. I., Safety and Immunogenicity of Full-Dose Trivalent Inactivated Influenza Vaccine (TIV) Compared With Half-Dose TIV Administered to Children 6 Through 35 Months of Age, J Pediatric Infect Dis Soc, vol. 4, no. 3, pp. 214-224, 2015.